Last reviewed · How we verify

NCT04048239: ROSA-IC

Development of a Robotic Minimally Invasive Pathway for Cochlear Implantation

Completed NA Last updated 19 September 2025
What this trial tests

NA trial testing cochlear implantation in Cochlear Hearing Loss in 9 participants. Completed in 12 September 2023.

Timeline
1 October 2019
Primary endpoint
12 September 2023
12 September 2023

Quick facts

Lead sponsorCentre Hospitalier Universitaire, Amiens
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment9
Start date1 October 2019
Primary completion12 September 2023
Estimated completion12 September 2023
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

Centre Hospitalier Universitaire, Amiens

Who can join

18 and older, any sex, with Cochlear Hearing Loss or Implant. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Cochlear Implantation is a system developed to restore hearing in people with profound sensorineural hearing loss, whose classical hearing aids are ineffective. Surgery is necessary to insert the internal part into the cochlea and requires milling the mastoid to access the round window. This approach is technically difficult, and is performed under a microscope by an experienced surgeon. The development of a surgical technique that is both safer and less invasive is currently possible thanks to robotics.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of cochlear implantation

Trials testing the same drug.

Other recruiting trials for Cochlear Hearing Loss

Currently open trials in the same condition.

Other Centre Hospitalier Universitaire, Amiens trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04048239.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing